Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations

Vaccination and anti‐viral therapy with nucleos(t)ide analogues (NAs) are key approaches to reducing the morbidity, mortality and transmission of hepatitis B virus (HBV) infection. However, the efficacy of these interventions may be reduced by the emergence of drug resistance‐associated mutations (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokaya, Jolynne, Vasylyeva, Tetyana I., Barnes, Eleanor, Ansari, M. Azim, Pybus, Oliver G., Matthews, Philippa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581767/
https://www.ncbi.nlm.nih.gov/pubmed/33893696
http://dx.doi.org/10.1111/jvh.13525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581767/
https://www.ncbi.nlm.nih.gov/pubmed/33893696
http://dx.doi.org/10.1111/jvh.13525

Ejemplares similares